Healthcare & Life Sciences
Halozyme Therapeutics
United Stateshalozyme.com/
Halozyme Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Halozyme Therapeutics
Based in the United States, Halozyme Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Halozyme Therapeutics develops drug delivery technologies, including ENHANZE®, that improve the administration and effectiveness of therapeutics to enhance patient outcomes.
Explore Halozyme Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.